Koninklijke Philips NV vs Quantum Computing Inc — how do they compare? Koninklijke Philips NV trades at $24.42 (market cap $23.52B), while Quantum Computing Inc trades at $7.47 (market cap $1.69B). The key difference: Koninklijke Philips NV is far larger — about 13.9× Quantum Computing Inc's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Quantum Computing Inc for 25 Days on average.
| PHG | QUBT | |
|---|---|---|
Market Cap | $23.52B | $1.69B |
Volume | 1,635,069 | 7,991,522 |
Sector | Health | Technology |
52-Week High | $32.91 | $21.78 |
52-Week Low | $23.81 | $6.31 |
Typical Hold Time | 84 Days | 25 Days |
Enterprise Value | $29.87B | $753.24M |
Dividend Yield | 4.17% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.09, down 0.25% with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly EPS beats and a return to profitability in 2025 (net income $895M). Recent news highlights innovation in healthcare technology including new product launches and AI partnerships. Valuation metrics appear reasonable with P/E of 18.94 and P/S of 1.18.
PHG presents a mixed outlook with strong operational recovery but technical weakness. The investment case hinges on continued earnings momentum and successful execution of healthcare technology initiatives. Key risks include competitive pressures and potential cybersecurity vulnerabilities following recent hacking incidents. Analyst consensus leans neutral with 36% buy ratings versus 64% hold.
Quantum Computing Inc. (QUBT) trades at $7.62, down 3.05% today, with a bearish technical signal despite bullish oscillators. The company shows explosive revenue growth from $682K in 2025 to $10M in 2026 but remains deeply unprofitable with a -152.45% net income margin. Recent developments include the Dirac-3S quantum system announcement and a $42.5M backlog, though rising expenses and cash burn persist.
Analysts maintain a bullish consensus with a $17.33 price target (75% buy ratings), seeing potential in QUBT's quantum technology expansion. However, significant execution risks, continued losses, and high valuation (P/S 157.36) create substantial downside potential if commercialization timelines slip or funding needs increase.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →